RGL2026-04-012026-06-30RGL2026-04-012026-06-30in-capmkt:OtherExpenses1MemberRGL2026-04-012026-06-30in-capmkt:OtherExpenses2MemberRGL2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1RGL2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2RGL2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss3RGL2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss4RGL2026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1RGL2026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares532923RGLNOTLISTEDINE722H01024Renaissance Global LimitedMain BoardEquity2026-04-012027-03-312026-08-072026-08-04INRLakhsQuarterlyFirst quarterSingle segmentJewellery2026-08-0716:00:002026-08-0718:50:00Not applicablefalsefalse1. The above unaudited Standalone Financial Results have been prepared in accordance with applicable Indian Accounting Standard as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the SEBI (LODR) 2015. The same were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on August 07 2026. The Statutory Auditors of the Company have carried out a limited review of the financial results for the quarter ended June 30 2026. <br /> <br /> 2. The Company is engaged primarily in the business of Jewellery and hence there is no separate reportable segment within the criteria defined under Indian Accounting Standard (Ind AS) -108 'Operating Segments. <br /> <br /> 3. During the quarter ended June 30 2025 and year ended March 31 2026 the expenses towards the closure of Bhavnagar unit aggregating to 1197.40 Lakhs has been disclosed as the exceptional item. <br /> <br /> 4. During the quarter ended June 30 2026: <br /> <br /> a) 51000 options were granted and <br /> b) 43000 options have been exercised by and allotted to grantees, pursuant to the RGL ESOP scheme 2021. <br /> As on June 30, 2026, 10,92,000 options are pending for exercise, and 10,70,500 options are available for new grant. The total number of ordinary equity shares outstanding as on June 30, 2026, is 10,73,68,471 after the above ESOP exercises. <br /> <br /> 5. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the unaudited published figures of nine months ended December 31, 2025. <br /> <br /> 6. The figures for the corresponding previous quarters / year have been re-grouped / rearranged wherever necessary, to make them comparable.2026-04-012026-06-30UnauditedStandalone43366620001411400043507760001907425000105691400051652600011558500081894000246930005166420004219679000131097000013109700033700000-4160000295400000101557000000010155700016465800026621500021473700020.950.95000.950.951. The above unaudited Standalone Financial Results have been prepared in accordance with applicable Indian Accounting Standard as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the SEBI (LODR) 2015. The same were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on August 07 2026. The Statutory Auditors of the Company have carried out a limited review of the financial results for the quarter ended June 30 2026. <br /> <br /> 2. The Company is engaged primarily in the business of Jewellery and hence there is no separate reportable segment within the criteria defined under Indian Accounting Standard (Ind AS) -108 'Operating Segments. <br /> <br /> 3. During the quarter ended June 30 2025 and year ended March 31 2026 the expenses towards the closure of Bhavnagar unit aggregating to 1197.40 Lakhs has been disclosed as the exceptional item. <br /> <br /> 4. During the quarter ended June 30 2026: <br /> <br /> a) 51000 options were granted and <br /> b) 43000 options have been exercised by and allotted to grantees, pursuant to the RGL ESOP scheme 2021. <br /> As on June 30, 2026, 10,92,000 options are pending for exercise, and 10,70,500 options are available for new grant. The total number of ordinary equity shares outstanding as on June 30, 2026, is 10,73,68,471 after the above ESOP exercises. <br /> <br /> 5. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the unaudited published figures of nine months ended December 31, 2025. <br /> <br /> 6. The figures for the corresponding previous quarters / year have been re-grouped / rearranged wherever necessary, to make them comparable.Foreign Exchange Loss (Net)132056000Other Expenses384586000Re-measurement gains (losses) on defined benefit plans0Equity instrument through OCI41084000Mutual fund equity instrument through OCI438000Income tax effect on above-11979000295430000Fair Value Changes on derivatives designated on cash flow hedges180558000Income tax efforts on above-454430001351150000164658000